Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harpo is a Polish biotechnology company specializing in the development and supply of advanced reagents for RNA research and mRNA synthesis. The company's Life Sciences division is a recognized provider of essential components such as cap analogs, modified nucleotides, and phosphoramidites, which are critical for the production of stable and efficient mRNA for vaccines and therapeutics. Based in Poznań, Harpo supports a global network of academic and industrial researchers by providing tools that optimize the translation and stability of synthetic RNA molecules. In addition to its biotech operations, the company has a long-standing history as a leader in assistive technology for individuals with visual and communication impairments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harpo.